GLENMARK PHARMACEUTICALS LIMITED

Analyst Reco. Glenmark Pharmaceuticals Limited

Equities

GLENMARK

INE935A01035

Market Closed - NSE India S.E. Other stock markets 07:58:32 2024-06-07 am EDT			5-day change	1st Jan Change
1,194 ^INR	-1.30%		+2.91%	+39.84%

May. 30	Transcript : Glenmark Pharmaceuticals Limited - Analyst/Investor Day
May. 29	Assertio Therapeutics Names Brendan O'Grady as Chief Executive	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nomura Adjusts Glenmark Pharmaceuticals’ Price Target to INR909 From INR841, Keeps at Neutral	Feb. 20	MT
Indian shares set to open higher ahead of national budget	Jan. 31	RE
Nomura Downgrades Glenmark Pharmaceuticals to Neutral From Buy, Adjusts Price Target to INR841 From INR633	23-09-26	MT
INDIA STOCKS-India's Sensex logs worst week in 15 months on rate worries	23-09-22	RE
Indian Equities Close Flat, Weighed Down by Worries Over US Rate Hikes, Weak Chinese Economy	23-08-22	MT
Nomura Adjusts Glenmark Pharmaceuticals' Price Target to INR633 From INR580, Keeps at Buy	23-02-14	MT
Nomura Adjusts Glenmark Pharmaceuticals' Price Target to 580 Indian Rupees From 757 Rupees, Keeps at Buy	22-11-30	MT
Indian shares may open higher, tracking Asia	22-10-26	RE
Crisil Keeps AA- Rating on Glenmark Pharmaceuticals; Raises Outlook to Positive	21-12-23	MT
S&P Raises Glenmark Pharmaceuticals' Rating to BB on Plan to Cut Debt	21-11-18	MT
GLENMARK PHARMACEUTICALS : Nomura Adjusts Glenmark Pharmaceuticals' Price Target to 757 Indian Rupees From 762 Indian Rupees, Keeps at Buy	21-08-24	MT
GLENMARK PHARMACEUTICALS : Nomura Adjusts Glenmark Pharmaceuticals' Price Target to 762 Indian Rupees From 727 Indian Rupees, Keeps at Buy	21-06-18	MT
Glenmark Pharmaceuticals : S&P Global Maintains Glenmark Pharmaceuticals' BB- Issuer Credit Rating; Outlook Stable	20-11-25	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer